Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
21 hedge funds and large institutions have $281K invested in Nemaura Medical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
5% less funds holding
Funds holding: 22 → 21 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less capital invested
Capital invested by funds: $699K → $281K (-$418K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9.98K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$5.11K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$4.17K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.31K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$53 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$239K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.53K |
| 3 |
VF
Virtu Financial
New York
|
-$4K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$158 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16 |
NMRD Hedge Fund Activity: Q4 2023 in Review
21 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q4 2023, worth a combined $281K — down 60% from $699K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NMRD and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $9.98K. The largest seller was Alyeska Investment Group, cutting an estimated $239K.
- 21 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q4 2023, down from 22 in Q3 2023.
- Funds reported $281K of Nemaura Medical, Inc. Common Stock stock for Q4 2023, down 60% quarter-over-quarter.
- 3 funds opened new Nemaura Medical, Inc. Common Stock positions in Q4 2023 and 4 closed out, a net change of -1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q4 2023 was Citadel Advisors, an estimated $9.98K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q4 2023 was Alyeska Investment Group, an estimated $239K sold.
Based on aggregated 13F filings for Q4 2023.